Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tort

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
European Journal of Biochemistry|April 15, 1997
Functional expression of Fasciola hepatica cathepsin L1 in Saccharomyces cerevisiaeL Roche, A J Dowd, J Tort, et al.
Expert Review of Vaccines|November 11, 2025
Healthcare providers' preferences for pediatric pneumococcal vaccination recommendations in the United StatesJeffrey Vietri, Kelley Myers, Liping Huang, et al.
Journal of Medical Economics|April 5, 2024
Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13Mark H Rozenbaum, Liping Huang, Alejandro Cane, et al.
Respiratory Medicine|March 23, 2025
Early-life pneumonia and subsequent risk of respiratory disease among commercial-insured and medicaid-insured children with and without high-risk conditionsAhuva Averin, Stephen I Pelton, Derek Weycker, et al.
Veterinary Parasitology|September 27, 2021
Evaluation of a Cooperia oncophora double-domain ASP-based vaccine against Cooperia spp. infections in cattle and sheepG Suárez, P Geldhof, J Borloo, et al.
Infectious Diseases and Therapy|March 16, 2024
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical ConditionsMark H Rozenbaum, Erica Chilson, Raymond Farkouh, et al.
Clinical and Vaccine Immunology : CVI|November 16, 2007
Leucine aminopeptidase is an immunodominant antigen of Fasciola hepatica excretory and secretory products in human infectionsA Marcilla, J E De la Rubia, J Sotillo, et al.
Vaccine|January 8, 2024
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infantsMark H Rozenbaum, Liping Huang, Johnna Perdrizet, et al.
American Journal of Rhinology & Allergy|October 13, 2017
Abstracts from the North American Rhinology & Allergy Conference, February 3, 2011, Puerto RicoW W Carr, D I Bernstein, F C Hampel, et al.
The Pediatric Infectious Disease Journal|November 7, 2025
Invasive Pneumococcal Disease at Eight Children's Hospitals in the United States, 2018-2023Sheldon L Kaplan, William J Barson, Philana Ling Lin, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
European Journal of Biochemistry|April 15, 1997
Functional expression of Fasciola hepatica cathepsin L1 in Saccharomyces cerevisiaeL Roche, A J Dowd, J Tort, et al.
Expert Review of Vaccines|November 11, 2025
Healthcare providers' preferences for pediatric pneumococcal vaccination recommendations in the United StatesJeffrey Vietri, Kelley Myers, Liping Huang, et al.
Journal of Medical Economics|April 5, 2024
Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13Mark H Rozenbaum, Liping Huang, Alejandro Cane, et al.
Respiratory Medicine|March 23, 2025
Early-life pneumonia and subsequent risk of respiratory disease among commercial-insured and medicaid-insured children with and without high-risk conditionsAhuva Averin, Stephen I Pelton, Derek Weycker, et al.
Veterinary Parasitology|September 27, 2021
Evaluation of a Cooperia oncophora double-domain ASP-based vaccine against Cooperia spp. infections in cattle and sheepG Suárez, P Geldhof, J Borloo, et al.
Infectious Diseases and Therapy|March 16, 2024
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical ConditionsMark H Rozenbaum, Erica Chilson, Raymond Farkouh, et al.
Clinical and Vaccine Immunology : CVI|November 16, 2007
Leucine aminopeptidase is an immunodominant antigen of Fasciola hepatica excretory and secretory products in human infectionsA Marcilla, J E De la Rubia, J Sotillo, et al.
Vaccine|January 8, 2024
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infantsMark H Rozenbaum, Liping Huang, Johnna Perdrizet, et al.
American Journal of Rhinology & Allergy|October 13, 2017
Abstracts from the North American Rhinology & Allergy Conference, February 3, 2011, Puerto RicoW W Carr, D I Bernstein, F C Hampel, et al.
The Pediatric Infectious Disease Journal|November 7, 2025
Invasive Pneumococcal Disease at Eight Children's Hospitals in the United States, 2018-2023Sheldon L Kaplan, William J Barson, Philana Ling Lin, et al.
Pageof 5